OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
Mithun Rudrapal, Neelutpal Gogoi, Dipak Chetia, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 4, pp. 2432-2446
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116

Development of new 2-(Benzothiazol-2-ylimino)-2,3-dihydro-1H-imidazol-4-ol complexes as a robust catalysts for synthesis of thiazole 6-carbonitrile derivatives supported by DFT studies
Mahmoud Abd El Aleem Ali Ali El‐Remaily, Omar M. Elhady, Aly Abdou, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136188-136188
Closed Access | Times Cited: 50

Herbal concoction Unveiled: A computational analysis of phytochemicals' pharmacokinetic and toxicological profiles using novel approach methodologies (NAMs)
Mansi Rai, Ajay Vikram Singh, Namuna Paudel, et al.
Current Research in Toxicology (2023) Vol. 5, pp. 100118-100118
Open Access | Times Cited: 47

Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints
Mithun Rudrapal, Kevser Kübra Kırboğa, Mohnad Abdalla, et al.
Molecular Diversity (2024) Vol. 28, Iss. 4, pp. 2099-2118
Closed Access | Times Cited: 24

Innovation, structural inspection for new mixed complexes: DNA binding, biomedical applications and molecular docking approaches
Faizah S. Aljohani, Tarek El‐Dabea, Rafat M. El‐Khatib, et al.
Journal of Taibah University for Science (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 23

Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors
Heba T. Abdel‐Mohsen, Marwa Ibrahim, Amira M. Nageeb, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 17

Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
Mithun Rudrapal, İsmail Çeli̇k, Johra Khan, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 3, pp. 101826-101826
Open Access | Times Cited: 63

Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
Mithun Rudrapal, İsmail Çeli̇k, Sampath Chinnam, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 5, pp. 3456-3465
Open Access | Times Cited: 46

Identification, characterization, and insights into the mechanism of novel dipeptidyl peptidase-IV inhibitory peptides from yak hemoglobin by in silico exploration, molecular docking, and in vitro assessment
Jin Zhang, Yulong Wu, Honggang Tang, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129191-129191
Closed Access | Times Cited: 11

Exploring caffeine as a disruptor of membrane integrity and genomic stability in Staphylococcus aureus: functional and in silico analysis
K. C. Beulah, Akshatha Prasanna, Prashantha Karunakar, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 2
Closed Access | Times Cited: 1

Silybin phytosome attenuates cerebral ischemia‐reperfusion injury in rats by suppressing oxidative stress and reducing inflammatory response: In vivo and in silico approaches
Praveen Kumar Pasala, Ramya K. Uppara, Mithun Rudrapal, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 7
Closed Access | Times Cited: 31

Investigation of Cardioprotective Activity of Silybin: Network Pharmacology, Molecular Docking, and In Vivo Studies
Praveen Kumar Pasala, Madhuri Donakonda, Dintakurthi Sree Naga Bala Krishna Prasanth, et al.
ChemistrySelect (2023) Vol. 8, Iss. 20
Closed Access | Times Cited: 17

Computational Investigations for Identification of Bioactive Molecules from Baccaurea ramiflora and Bergenia ciliata as Inhibitors of SARS-CoV-2 Mpro
James H. Zothantluanga, Mohnad Abdalla, Mithun Rudrapal, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 3, pp. 2459-2487
Closed Access | Times Cited: 28

Valorization of Adhatoda vasica leaves: Extraction, in vitro analyses and in silico approaches
Mithun Rudrapal, Sugumari Vallinayagam, Sahar M. Aldosari, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 16

Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 Mpro inhibitor
Abd. Kakhar Umar, James H. Zothantluanga, Jittima Amie Luckanagul, et al.
PeerJ (2023) Vol. 11, pp. e14915-e14915
Open Access | Times Cited: 14

A computational study of Di-substituted 1,2,3-triazole derivatives as potential drug candidates against Mycobacterium tuberculosis: 3D-QSAR, molecular docking, molecular dynamics, and ADMETox
Yassine Koubi, Youness Moukhliss, Halima Hajji, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 25, pp. 11832-11841
Closed Access | Times Cited: 11

Computational Studies of Cannabis Derivatives as Potential Inhibitors of SARS-CoV-2 Mpro
Nouh Mounadi, Hassan Nour, Ossama Daouı, et al.
Chemistry Africa (2024) Vol. 7, Iss. 5, pp. 2569-2580
Closed Access | Times Cited: 4

Determination of the Inhibitory Potential of Chalcones on Myeloperoxidase Enzyme Activity: In vitro and Molecular Docking Studies
Nurgül Abul, Yeliz Demir, Aykut Öztekіn, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access

Novel Benzosuberone/Indanone‐Linked Thiazoles as Small‐Molecule SARS‐CoV‐2 Main Protease Inhibitors
Thoraya A. Farghaly, Elham N. Bifari, Mariam A. Al‐Sheikh, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access

Molecular docking and in vivo immunomodulatory activity of Albizia procera bark on doxorubicin induced immunosuppressive rats
Praveen Kumar Pasala, L. Siva Sankar Reddy, Netala Silvia, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 3, pp. 101828-101828
Open Access | Times Cited: 18

Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors
Mubarak A. Alamri, Muhammad Usman Mirza, Muhammad Muzammal Adeel, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 659-659
Open Access | Times Cited: 17

Computational approaches to define poncirin from Magnolia champaka leaves as a novel multi-target inhibitor of SARS-CoV-2
Shashank M. Patil, Bhaskar Phanindra, Prithvi S. Shirahatti, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13078-13097
Closed Access | Times Cited: 10

Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis
Burhan Ul Haq, Hina Qayoom, Shazia Sofi, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top